LYPD3 and cancer: Clearly, further analyses such as coimmunoprecipitation are required to confirm that these interactions occur in clinical cancers but the consistency of the yeast 2-hybrid data, the expression profile of C4.4a and the previously reported links of DAG-1 and C4.4a to cancer make these interactions intriguing enough to warrant further investigation.